Immunocore Holdings Ltd (IMCR) — Financial Flexibility Index
Immunocore Holdings Ltd (IMCR) has a Financial Flexibility Index of -0.01x as of September 2025. Free cash flow of $-3.71 Million (operating CF $-4.46 Million minus capex $748.00K) represents 0% of total liabilities ($705.94 Million). Check how strategically is Immunocore Holdings Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Immunocore Holdings Ltd Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for Immunocore Holdings Ltd across 7 annual periods. See working capital position of Immunocore Holdings Ltd to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Immunocore Holdings Ltd (2018–2024)
Year-by-year free cash flow to debt coverage for Immunocore Holdings Ltd. For the full company profile including market capitalisation, see Immunocore Holdings Ltd stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.05x | $31.23 Million | $26.06 Million | $648.79 Million | ▲ +31.3% |
| 2023 | 0.04x | $8.37 Million | $2.94 Million | $228.16 Million | ▲ +114.7% |
| 2022 | -0.25x | $-47.01 Million | $-49.21 Million | $187.86 Million | ▲ +69.0% |
| 2021 | -0.81x | $-141.72 Million | $-143.11 Million | $175.76 Million | ▼ -98.9% |
| 2020 | -0.41x | $-57.50 Million | $-60.57 Million | $141.85 Million | ▲ +5.5% |
| 2019 | -0.43x | $-97.10 Million | $-101.38 Million | $226.37 Million | ▼ -356.2% |
| 2018 | -0.09x | $-13.09 Million | $-16.63 Million | $139.19 Million | — |